Centene (Centene) Retained Earnings : $12,043 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Centene Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Centene's retained earnings for the quarter that ended in Dec. 2023 was $12,043 Mil.

Centene's quarterly retained earnings increased from Jun. 2023 ($11,529 Mil) to Sep. 2023 ($11,998 Mil) and increased from Sep. 2023 ($11,998 Mil) to Dec. 2023 ($12,043 Mil).

Centene's annual retained earnings increased from Dec. 2021 ($8,139 Mil) to Dec. 2022 ($9,341 Mil) and increased from Dec. 2022 ($9,341 Mil) to Dec. 2023 ($12,043 Mil).

Centene Retained Earnings Historical Data

The historical data trend for Centene's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Retained Earnings Chart

Centene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

4,984.00

6,792.00

8,139.00

9,341.00

12,043.00

Centene Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Retained Earnings	Get a 7-Day Free Trial															9,341.00	10,471.00	11,529.00	11,998.00	12,043.00

Centene Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Centene (NYSE:CNC) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Centene (Centene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

CNC:Mexico 1CNC:Italy QEN:Germany QEN:Germany C1NC34:Brazil

Address

7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105

Website

https://www.centene.com

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Executives

Lori Jean Robinson	director	5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher	officer: EVP, CFO	8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray	officer: EVP, Chief Transform. Officer	500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii	director	1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford	director	C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola	officer: EVP, Health Care Enterprises	500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley	officer: EVP, Chief Admin. Officer	7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt	director	822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin	director
H James Dallas	director	127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks	officer: SVP, Chief Information Officer	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas	officer: EVP, MARKETS	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk	director	C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A	officer: EVP, Mergers & Acquisitions	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105